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Abstract
Background: Ficolin-2 coded by FCN2 gene is a soluble serum protein that plays an important role in innate immunity. In this
study, we analyzed five functional polymorphisms of the FCN2 gene for their possible association with cutaneous leishmaniasis.
Methods: Initially we screened 40 Syrian Arabs for the entire FCN2 gene. We investigated the contribution of FCN2
functional variants in 226 patients with cutaneous leishmaniasis and 286 healthy controls from Syria. Polymorphisms in the
promoter regions (2986G/A, 2602G/A, 24A/G) of the FCN2 gene were assessed by TaqMan real time PCR, whereas
polymorphisms in exon8 (+6359C/T and +6424G/T) were assessed by DNA sequencing. We also measured serum ficolin-2
levels in 70 control Syrian Arabs and correlated the serum concentrations to FCN2 genotypes and haplotypes respectively.
Results: Nine new FCN2 variants including two with non synonymous substitutions in exon6 and exon8 were observed. The
homozygous genotypes +6424T/T were distributed more in controls and none in patients (P=0.04). The AGACG haplotype
were observed more in patients than in controls (OR=2.0, 95%CI 1.2–3.4, P=0.006). The serum ficolin-2 levels were
significantly distributed among the reconstructed ficolin-2 haplotypes (P,0.008) and the haplotype AGACG was observed
with higher ficolin-2 levels in 70 control individuals.
Conclusion: Our results demonstrate a significant association of FCN2 AGACG haplotype with cutaneous leishmaniasis in a
Syrian Arab population. These first results provide a basis for a future study that could confirm or disprove possible
relationships between FCN2 gene polymorphisms with cutaneous leishmaniasis.
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Introduction
Leishmaniasis is caused by protozoan parasite of the genus
Leishmania and poses a serious health threat in many tropical and
subtropical countries with estimated 350 million people at risk and
12 million people affected. Despite considerable efforts to control
the disease the incidence worldwide is still on the rise. Three distinct
clinical forms, cutaneous (CL), visceral (VL) and mucocutaneous
leishmaniasis(MCL) areclassicallycausedbya spectrumofdifferent
Leishmania species [1]. Although there is a clear correlation between
the causative species and the clinical presentation, many variations
are observed depending on the immunocompetence of the host [2].
Resistance against leishmaniasis depends on a Th1-type response
resulting in the production of interferon gamma whereas Th2-type
response is related to susceptibility [1,3]. Apart from the
characteristics of the species and strains, the hosts innate immunity
influences the severity of the disease to a great extent [4,5].
Genome-wide studies have been performed to define quantitative
trait loci (QTL) in mice and in humans with CL and VL caused by
L. major [6]. Some of the identified QTL seems to be rather species-
specific while a few play a role in other parasitic diseases [7].
In this study, we aim to investigate the contribution of ficolin-2
(FCN2) gene polymorphisms to the susceptibility for leishmaniasis
caused by L. tropica in a Syrian cohort. Ficolin-2 is an important
factoroftheinnate immuneresponseand is located onchromosome
9q34 and contains eight exons [8–10]. Ficolin-2 binds to different
pathogen–associated molecular patterns (PAMPs), such as carbo-
hydrates, lipoteichoic acid and acetylated groups leading to the
pathogen phagocytosis and activation of complement system
through the lectin pathway [11]. The repertoire of microorganisms
recognized by ficolin-2 may be as widespread as for the mannan–
binding lectin (MBL). Recent studies have demonstrated MBL
binds to L. braziliensis and the MBL binding is mediated by a specific
carbohydrate on the parasite surface [12]. It has been recently
shown that FCN2 is highly polymorphic and that low levels of
circulating ficolin-2 are clearly associated with polymorphisms in
the promoter (2986G/A, 2602G/A, 24A/G) and in exon 8
(+6359C/T and +6424G/T) of the gene [10,13]. Although so far no
total deficiency of ficolin-2 has been reported, low circulating levels
of the protein have been shown to be associated with recurrent
respiratoryinfectionsinchildren[14],tocontributetotheseverityof
renal disease in IgA nephropathy [15] and in autoimmune diseases
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between FCN2 gene polymorphisms to ficolin-2 levels in rheumatic
fever, rheumatic heart disease, leprosy, hepatitis B virus and malaria
[16–19]. In the current study, we aim to investigate the role of five
functional FCN2 gene polymorphisms (2986G/A, 2602G/A, 24A/
G, +6359C/T and +6424G/T) for a possible association to the
leishmaniasis outcome in a Syrian cohort. Further in the case
control analysis, we aim to compare and relate any possible
outcome caused either by the genotypes or by the haplotypes that
were established to influence serum ficolin levels.
Materials and Methods
Ethics
Informed written consent was given by all participants. The
study was approved by the local ethics committee of the University
of Damascus and also approved by the Ministry of Health, Syria.
Patients and sampling
A total of 226 patients from Syria presenting different clinical
outcomes of cutaneous leishmaniasis characterised by a lesion
(‘‘Aleppo boil’’; (87 (37%) females and 148 (63%) males, mean age
26615 S.D years) were included in the study. They were
consecutive outpatients from different dermatologic clinics in
Syria. All patients were diagnosed with cutaneous leishmaniasis
according to clinical features and Giemsa staining of dermal
scrapings from affected lesions. Also 286 healthy unrelated
symptom-free subjects were assessed as controls (87 (38%) females
and 145 (62%) males, mean age 26613 S. D years). Both patients
and controls belonged to the same social status, geographical area
and Arabic ethnic background. The participants of the study were
recruited between March 2008 and March 2009 and in December
2011. All patients and control subjects signed an informed written
consent.
Genomic DNA isolation and FCN2 genotyping
Three ml of venous whole blood was drawn from the study
subjects. DNA extraction was performed using QIAamp
TM DNA
extraction kits following the manufacturer’s instructions (QIAGEN
GmbH, Hilden, Germany). The entire coding regions of the gene
were amplified in 40 control individuals and were analyzed by
direct DNA sequencing. DNA was amplified using a primer pair
spanning one or two exons (Table 1). In brief: 100 ng of genomic
DNA was amplified in a 25 ml volume of reaction mixture
containing 16reaction buffer (20 mM Tris pH 8.8, 10 mM KCl,
1.5 mM MgCl2 and 0. 1% Triton X-100), 16 Q-solution
(QIAGEN), 0.2 mM dNTPs, 0.5 mM MgCl2, 0.5 mM of each
primer and 1.0 U Taq polymerase (QIAGEN). The cycling
conditions used for amplification were 95uC for 5 min; 35 cycles of
95uC for 40 s, 59uC for 60 s, 72uC for 90 s, and with a final
extension of 72uC for 3 min. The amplified PCR fragments were
stained with SyBrgreen I (Biozym Diagnostik GmbH, Wien,
Austria) and visualized on a 1% agarose gel. The PCR products
were purified by using the EZNA Cycle-Pure kit following
manufacturer’s instructions (PeqLab Biotechnologie GmbH,
Erlangen, Germany). Purified PCR products were then sequenced
with the BigDyeH Terminator v1. 1 Cycle Sequencing Kit
(Applied Biosystems, Foster City, CA, USA). Sequencing reactions
were analysed on an automated sequencer (ABI Prism 3100
Genetic Analyzer, Applied Biosystems). The resulting DNA
sequences were aligned using Bio-Edit software, and DNA
polymorphisms were confirmed visually from sequence electro-
pherograms. The identified novel polymorphisms were submitted
to the SNPper database and appropriate SNP #rs IDs were
received.
The determination of polymorphism at 2986G.A, 2602G.A
and 24A.G in the promoter regions were investigated by
TaqMan-Real-Time PCR (TaqMan MGE assay, Applied Biosys-
tems, Foster City, CA, USA), whereas for the positions +6359C.T
and +6424G.T DNA sequencing method was employed. The
TaqMan-Real-Time PCR technique is based on amplification of
the region flanking the SNP in the presence of two allele-specific
fluorescent probes, of which the 59end is labelled with a reporter
dye (either FAM or YAK) and the 39 end is labelled with a
quencher dye (Table 2). Both alleles can be detected in a single
Table 1. Primer pairs utilized for characterization of the entire FCN2 gene in 40 Syrian Arabs.
Reverse primer Forward primer
59- gaa gcc acc aat cac gaa g- 39 59- att gaa gga aaa tcc gat ggg- 39 Promoter+Exon 1
59- gtt cct ctg cag cca ggt c- 39 59- aga tgg cag atg cct ttc ag- 39 Exon 2+3
59- agg ctc ttg tgt tcc agg c- 39 59- agg ccc aga aaa tgg tgt c- 39 Exon 4+6
59-ata cag acg cct atg gcc c- 39 Exon 5*
59- tta caa acc gta ggg cca ag- 39 59- cca gct ccc atg tct aaa gg- 39 Exon 7+8
*used only for sequencing.
doi:10.1371/journal.pone.0034113.t001
Table 2. Primers and probes employed for genotyping three
promoter SNPs in the FCN2 gene.
Position Primer/Probe Sequence
2986G.A Primers 59-tgatcttgccaaggaagaaggc-39
59- ccactaccaccaccgca -39
Probes 59-YAK-acctgccgccatcgg- BBQ3
59 -FAM-acctgctgccatcggga- BBQ39
2602G.A Primers 59-tccccactcttctctcctttcc-39
59-cctggggcagtatgtagagca-39
Probes 59-YAK-tcctgttcgtgtgcccc-BBQ39
59-FAM-tcctgttcatgtgcccctg-BBQ39
24A.G Primers 59- aagatgagaaattggagtctgaggga- 39
59-gaaagagagcagcagggtgg-39
Probes 59-YAK- ctccatctcctctggtctttgctt - BBQ39
59-FAM- agctccatctcttctggtctttgc - BBQ39
YAK and FAM are the reporter fluorophores Yakima Yellow and Fluorescein,
respectively.
Each probe carries at the 39-end the dark BBQ (BlackBerry Quencher).
doi:10.1371/journal.pone.0034113.t002
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quencher activity at the 39end. During the PCR, the exact
matching hybridization probe remains bound and is degraded.
Then the fluorophore is released and detected. A mismatch probe
abolishes the hybridization of the probe and no degradation and
subsequently no fluorophore can be detected.
For each allele-specific reaction, 12.5 mlo fT a q M a nU n i v e r s a l
Master Mix, 5 mM of forward and reverse primer, 1 mlo fp r o b e
labelled with 10 mM FAM and 1 ml of probe labelled with 10 mM
YAK and 20 ng of DNA diluted in 6.5 mlo fH 2Ow e r ed i s p e n s e d
under the following conditions in a 0.1 ml tube for each reaction
(Corbett Research LTF-Labortechnik GmbH, Wasserburg, Ger-
many): polymerase activation for 15 minute at 95uC 40 two-step
cycles consisting of: 60 s of denaturation at 94uCf o l l o w e db y
1 minute of annealing and elongation at 60uC.Resultswere analyzed
on Rotor-Gene 3000 using Rotor-Gene software v 6. 1 (Corbett Life
Science, Australia). Genotype results were manually assigned.
Ficolin-2 ELISA
The ficolin-2 concentrations were measured in sera in 70 Syrian
Arab controls using the human ficolin-2 ELISA kit (Hycult Biotech
Cat.#: HK336, Uden, The Netherlands) according to the
manufacturer’s instructions. The minimum ficolin-2 concentra-
tions that can be measured by this kit are 16 ng/mL.
Statistical analysis
Data had been analysed by STATA (Stata Corporation, Texas,
USA) and the level of significance was set to P,0.05. Normal Chi
square, Kruskal-Wallis test and two tailed Fisher’s exact tests were
executed to determine the differences in genotype, haplotype and
ficolin-2 level distributions. Genotype or haplotype frequencies
were determined by simple gene counting and by using the
expectation-maximum (EM) algorithm. The significance of
deviations from Hardy-Weinberg equilibrium and exact tests for
population differentiation was tested using the random-permuta-
tion procedure and by default Markov chain parameters as
implemented in the Arlequin v. 3.5.1.2 software (http://cmpg.
unibe.ch/software/arlequin3/). Linkage disequilibrium (LD) anal-
ysis was performed using Haploview v. 3.2 program.
Results
Initial screening of 40 control subjects revealed nine novel SNPs:
two in the promoter (2722C.T, 2418G.A), one in intron2
(+1898G.C), four in intron5 (+4577C.G, +4647C.T, +4704G.C,
+4806G.A), one in exon6 (+4986C.T)c a u s i n ga m i n oa c i d
substitution from Arg to Trp and one in exon8 (+6584G.A)c a u s i n g
a change at position 311 from Arg to Gln (Table 3). The limited
group size does not allow any analysis for low frequency SNPs. For
the patient-control cohort, we analysed three functional SNPs in the
promoter region (2986G.A, 2602G.Aa n d24A.G)a n dt w oi n
exon8 (+6359C.T and +6424G.T). The distribution of five
investigated functional SNPs was homogeneous in both patients
and controls. Both genotype and allele frequencies for all analysed
SNP variants (2986G.A, 2602G.A, 24A.G, +6359C.T,
+6424G.T) in controls and patients were in Hardy-Weinberg
equilibrium. When looked at the +6424G.T variant in exon8 we
found a statistically significant difference in genotypes between
patients and controls: in the control cohort we found five individuals
among 286 homozygous for +6424T/T (resulting in Ser at position
258 in the protein and leading to a low ficolin-2 level) but none
a m o n gi n d i v i d u a l si nt h ep a t i e n tc o h o r t( P=0.04). The loci
(2986G.A and 24A.G,)a n d( 2557A.G and 264A.C)i nt h e
Syrian cohort were highly linked to each other (Figure 1). Linkage
disequilibrium analysis revealed strong allelic combinations at posi-
tions (2986G.A, and 2602G.A) and (24A.G, and +6359C.T)in
the controls (Figure 2A) and 2986G.A, 2602G.Aa n d24A.G in
CL patients (Figure 2B). The AGACG (2986G.A, 2602G.A,
24A.G, +6359C.T, +6424G.T ) haplotype was associated with
CL.The AGACG haplotype was observed morein patients than in the
controls (9.3% vs. 4.9%, OR=2.0, 95%CI 1.2–3.4, p=0.006)
(Table 4). No significant distribution was observed between patients
and controls when the haplotypes associated with higher ficolin levels
(AAAG+AGGG+AGAG+GGGG) were compared to haplotypes associ-
ated with lower ficolin levels (GGAT ). Also when haplotypes
associated with medium ficolin levels (GGAG) were included to
haplotypes associated with higher ficolin levels (AAAG+AGGG+A-
GAG+GGGG); no significant association was observed between
patients and controls (Data not shown). Two FCN2 genotypes
(2602G.A and +6424G.T ) were correlated to serum ficolin-2
levels in a gene dose dependent manner i.e. homozygotes had
either the highest or the lowest Ficolin-2 concentrations, whereas
heterozygotes had intermediate concentrations (Data not shown).
The serum ficolin 2 levels were significantly distributed among the
reconstructed ficolin2 haplotypes (P,0.008) (Figure 3).
Table 3. Characterization of the entire FCN2 gene in 40 Syrian
Arabs.
Base
position
SNP
rs#.
Major
allele
Minor
allele
Major
allele
Minor
allele
2986 rs3124952 G A 0. 50 0. 50
2722 rs76739162 C T 0. 99 0. 01
2602 rs3124953 G A 0. 71 0. 29
2557 rs3811140 A G 0. 73 0. 27
2418 rs74693003 G A 0. 99 0. 01
2214 rs12344051 G A 0. 97 0. 03
264 rs28969369 A C 0. 86 0. 14
24 rs17514136 A G 0. 81 0. 19
1878 rs3124955 T C 0. 62 0. 38
1898 rs75577478 G C 0. 97 0. 03
2051 rs73565973 T C 0. 90 0. 10
2088 rs73565979 C T 0. 90 0. 10
2182 rs12344423 G A 0. 51 0. 49
2417 rs7024491 A G 0. 66 0. 34
2472 rs3128624 A G 0. 63 0. 37
2488 rs4520243 T C 0. 62 0. 38
2545 rs7037264 G A 0. 63 0. 37
4577 rs76665625 C G 0. 99 0. 01
4647 rs75123259 C T 0. 99 0. 01
4704 rs56117058 G C 0. 86 0. 14
4806 rs77254375 G A 0. 99 0. 01
4888 rs56200327 C T 0. 99 0. 01
6031 rs11103563 A G 0. 97 0. 03
6183 rs62573178 G A 0. 92 0. 08
6220 rs7872508 T G 0. 97 0. 03
6359 rs17549193 C T 0. 81 0. 19
6424 rs7851696 G T 0. 97 0. 03
6584 rs76267164 G A 0. 99 0. 01
In bold=new SNPs.
doi:10.1371/journal.pone.0034113.t003
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In Syria, 85% of cutaneous leishmaniasis is caused by L. tropica,
the remaining 15% stem from L. major. Visceral leishmaniasis can
be found in Syria but only in very low numbers and usually full
blown disease does not develop [20]. In contrast, CL is found in
larger numbers and is on the rise at times [21,22]. For these two
reasons we restricted our study to CL. Three main components of
the host–parasite interaction in leishmaniasis determine the disease
outcome: the host’s genetic background, the immunological
response and the parasite’s intrinsic pathogenicity. Many authors
have studied the influence of parasite strain and species on disease
[23]. Fewer data are available on the influence of host factors.
An association of functional polymorphisms in four cytokine
genes with susceptibility to, and clinical outcome of cutaneous
leishmaniasis has been shown, suggesting that functional genetic
variants in the interleukin 4 (IL4) promoter could influence the risk
of developing cutaneous leishmaniasis while the polymorphism in
the first intron of the interferon (IFN)-gamma gene might influence
the progression of disease towards chronic cutaneous leishmaniasis
[24]. Genome-wide scan analyses have identified different
chromosomal regions, which are involved in the development of
different clinical forms for leishmaniasis. The findings indicate that
multiple genes may control this immune response, probably with a
strong ethnic component as an additive factor [25–28].
Considering the physiopathology of Leishmania infections,
susceptibility to leishmaniasis seems to depend on early mecha-
nisms that provide the interaction of Leishmania and phagocytes/
macrophages [5]. Monocytes/macrophages provide the cellular
habitat for the parasite and phagocytosis remains a vital step in the
establishment of infection. Ficolin-2 and MBL are host opsonins
that bind to surface of various pathogens and interact with the
same molecules to be taken up by phagocytes [29,30]. Followed by
the entry of Leishmania into the host cell the cytokine response is
modulated to favour IL6 secretion which inhibits the antiparasitic
properties of macrophages [31]. High level of MBL and associated
genetic variants of MBL2 haplotypes are therefore found more
frequently in leishmaniasis patients than in healthy controls [32].
Hence MBL-deficient individuals are shown to be protected
against entry of Leishmania to the host cells; this heterosis effect has
also been observed for bacterial infections [33,34]. However, we
were not able to show binding of ficolin-2 to Leishmania surfaces as
it was demonstrated for Trypanosoma with subsequent killing of
the parasites [35]. The reasons for this may be of technical or
methodological difficulties.
Figure 2. Haploview plot illustrating the linkage disequilibrium of the FCN2 functional variants in controls (2A) and patients (2B). At
the top the SNPs are shown according to their succession from the start of translation of the FCN2 gene. Empty squares indicate a high degree of LD
(LD coefficient D9=1) between pairs of markers. Numbers indicate the D9 value expressed as a percentile. Red squares indicate pairs in strong LD with
LOD scores for LD $70; purple squares, D9=1 with LOD .1; white squares,D 9, 1.0 and LOD #2.
doi:10.1371/journal.pone.0034113.g002
Figure 1. Haploview plot illustrating the linkage disequilibrium
of the FCN2 promoter region from 40 healthy Syrian individ-
uals. At the top the SNPs are shown according to their succession from
the start of translation of the FCN2 gene. Empty squares indicate a high
degree of LD (LD coefficient D9=1) between pairs of markers. Numbers
indicate the D9 value expressed as a percentile. Red squares indicate
pairs in strong LD with LOD scores for LD $2; purple squares, D9=1
with LOD=2; white squares,D 9, 1.0 and LOD #2.
doi:10.1371/journal.pone.0034113.g001
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that ficolin-2 may be of biological significance in the host
interaction with Leishmania and as such has a role both in the
initiation as well as in the clinical outcome of the disease. Thus
ficolin-2 insufficiencies might play an advantageous role in the
protection against Leishmania as do MBL2 polymorphisms for
bacterial infections [33,34]. Since we do not have access to Syrian
patient samples to determine the contribution of FCN2 variants to
serum ficolin 2 levels, we sampled additional seventy healthy
control individuals and correlated their ficolin-2 serum levels with
respective genotype and haplotype distribution. We observed no
significant distribution between serum ficolin-2 levels and FCN2
functional genotypes. Earlier studies have documented that ficolin-
2 serum concentration was distributed in a gene dose-dependent
manner, i.e. homozygotes had either the highest or the lowest
ficolin-2 concentrations, whereas heterozygotes had intermediate
Table 4. FCN2 haplotypes in Cutaneous Leishmaniasis patients and healthy controls.
FCN2 haploytpes
(2986/2602/24/+6359/+6424)
Patients
n=452 (%)
Healthy controls
n=572 (%) OR (95% CI) P
AAACG 79 (17.5) 118 (20.6) NS
GGACG 160 (35.4) 206 (36.0) NS
AGGTG 116 (25.7) 136 (23.8) NS
AGACG 42 (9.3) 28 (4.9) 2.0 (1.2–3.4) 0.006
GGACT 37 (8.2) 46 (8.0) NS
AGGCG 9 (2.0) 3 (0.5) NS
GGATG 6 (1.3) 15 (2.6) NS
GGATT 1 (0.2) 6 (1.0) NS
AGATG 0 3 (0.5) NS
AAATG 1 (0.2) 4 (0.7) NS
GGGTG 0 3 (0.5) NS
AGGTT 0 2 (0.3) NS
GAACG 0 2 (0.3) NS
AAACT 1 (0.2) 0 NS
doi:10.1371/journal.pone.0034113.t004
Figure 3. Distribution of serum ficolin levels to five major haplotypes (2986/2602/24/+6359/+6424) in 70 control individuals.
doi:10.1371/journal.pone.0034113.g003
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trend was observed for the two FCN2 functional genotypes
(2602G.A and +6424G.T) to serum ficolin-2 levels. The lack of
significant distribution may possibly due to lower sample size
employed (n=70). Nevertheless, a significant distribution among
the reconstructed FCN2 haplotypes was observed (P,0.008).
Studies have documented a significant association of FCN2
promoter genotypes (2986G.A, 2602G.A and 24A.G)t o
serum ficolin levels in a Danish population and also on significant
associations of the FCN2 haplotypes (AAAG, AGAG, AGGG, GGAG
and GGAT) with serum ficolin-2 levels in Gabonese children with
mild malaria and the AAAG haplotype was associated with the
highest ficolin levels [13,36]. As observed from other studies, we
do not observe a significant contribution of the FCN2 genotypes;
however, we observed that the AGACG haplotypes contributed to
increased susceptibility to cutaneous Leishmaniasis. When looked
at the +6424G.T variant in exon8, we found a statistically
significant difference in genotypes between patients and controls.
Also the AGACG haplotype contributed towards increased
susceptibility to cutaneous leishmaniasis. These first results in the
Arab population with CL provide a basis for a future study that
could confirm or disprove these possible relationships. We also
found a statistically significant difference in +6424G.T variant
between patients and controls. Studies have demonstrated that the
+6424G.T variant is associated with low ficolin 2 protein
concentration and +6359C.T has lower GlcNAc binding capacity
and is much more frequent than the +6424G.T variant [10]. We
observed these +6424G.T variants more in patients that signifies
an increased lectin (GlcNAc-binding) activity in patient population
which effectively means the mechanism to thwart the CL infection
is happening. No significant association was observed between
haplotypes producing higher ficolin levels and that of haplotypes
with lower ficolin levels. Of which the AGAG haplotype (higher
ficolin-2 level producer) that was observed marginally significant in
patients does not reflect actual higher ficolin levels. Also the
+6424G.T variant (associated to lower ficolin levels) found
significantly higher in patients does not imply a factual outcome
on ficolin-2 levels. These associations have to be confirmed by
measuring the serum ficolin levels in this cohort.
The frequency of the studied SNPs in the Arabs resembles
largely the European distribution [37], except for 2557A.G and
264A.C, that were 0.27 and 0.14 in frequency in the Syrian
population compared to 0.12 and 0.02 in Danish population. The
population differentiation tests computed for genotypes that were
highly linked (2557A.G and 264A.C) in Syrian population were
observed to be significantly different to that of Danish genotypes
(P=0.001) [13]. It seems therefore that selective forces have
exerted positive selective pressure on FCN2 haplotypes that would
have conferred protection against some diseases. Although
cutaneous leishmaniasis does not lead to mortality, an influence
on the gene pool can easily be envisaged by the strong social
stigmatization of leishmaniasis patients, which can lead to social
exclusion including divorce [38,39]. Also, human beings affected
with severe skin disfigurations suffer a serious loss of quality of life
that may lead to suicidal ideation and suicide itself [40–42]. Of
course, it might be possible that other fatal diseases like
tuberculosis exerts the selective force on the FCN2 polymorphisms
and Leishmania profits from this selective process. Studies on this
subject are not yet available. In order to validate whether FCN2
polymorphisms are as a result of selection or stochastic factors, it is
essential to look at a larger population.
Overall, we present evidence that FCN2 polymorphisms may be
an additional factor contributing to the susceptibility to leishman-
iasis. Although the role of ficolin-2 in the interaction with the
Leishmania surface remains to be established, these results indicate a
role for this molecule in leishmaniasis and represent another
example how seemingly disadvantageous polymorphism can be
beneficial in a population. The association of the specific
haplotype is rather weak and the number of patients is low
therefore additional studies with larger cohorts having more severe
forms of leishmaniasis would be desirable.
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